Kirkstall Company Profile: Funding & Investors

Kirkstall Overview

Founded
2006

Status
Private

Employees
5

Latest Deal Type
PE Growth

Financing Rounds
11

Kirkstall General Information

Description

Developer of an advanced interconnected cell culture flow system intended to satisfy the overwhelming need for more human-relevant science, brought about by the failures of traditional in vitro research and animal research models. The company engages in developing a system of interconnected chambers for cell and tissue culture in laboratories, enabling researchers to test the drugs on living tissues reducing the need for expensive animal testing and thus improving the chances of success in human clinical trials.

Contact Information

Website

www.kirkstall.com

Ownership Status

Privately Held (backing)

Financing Status

Private Equity-Backed

Primary Industry

Biotechnology

Primary Office

York House
Outgang Lane, York
North Yorkshire YO19 5UP
England, United Kingdom

+44 01709 000000







Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kirkstall Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore Kirkstall‘s full profile, request access.

Request a free trial

Kirkstall Patents

18
Total Documents Applications and Grants
000
Total Patents Families
1
Granted
1
Pending
000
Expiring in next 12 mo

Kirkstall Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)	Citations
GB-202216700-D0	Bioreactor	Pending	09-Nov-2022
GB-201609401-D0	Bioreactor chamber insert	Inactive	27-May-2016
GB-0908400-D0	Improved bioreactor chamber	Inactive	15-May-2009
GB-0908404-D0	Multi-cavity bioreactor chamber	Inactive	15-May-2009	000000000
GB-2470227-A	Multi-cavity bioreactor chamber	Inactive	15-May-2009	C12M25/02	0